What is PTC Therapeutics's EV / sales?

PTC Therapeutics (PTCT) reported EV / sales of 6.3× in Q1 2026.

How has PTC Therapeutics's EV / sales changed year-over-year?

PTC Therapeutics's EV / sales increased by 280.0% year-over-year, from 1.7× to 6.3×.

What is the long-term trend for PTC Therapeutics's EV / sales?

Over 5 years (2020 to 2025), PTC Therapeutics's EV / sales has grown at a -23.2% compound annual growth rate (CAGR), from 11.9× to 3.2×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

PTC Therapeutics PTCT EV / sales

EV / sales at other companies

BioMarin PharmaceuticalsBMRN

2.8×-1.6×

ALN

Alnylam PharmaceuticalsALNY

9.9×-4.7×

BridgeBio PharmaBBIO

28.9×-18.5×

Arrowhead ResearchARWR

14×+10.9×

BiogenBIIB

3×+0.8×

Protagonist TherapeuticsPTGX

88.3×+74.7×

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Calculated from PTC Therapeutics’s reported figures.

enterprise value/total revenue=6.3×

Based on the most recent quarter.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's EV / sales?: PTC Therapeutics (PTCT) reported EV / sales of 6.3× in Q1 2026.
How has PTC Therapeutics's EV / sales changed year-over-year?: PTC Therapeutics's EV / sales increased by 280.0% year-over-year, from 1.7× to 6.3×.
What is the long-term trend for PTC Therapeutics's EV / sales?: Over 5 years (2020 to 2025), PTC Therapeutics's EV / sales has grown at a -23.2% compound annual growth rate (CAGR), from 11.9× to 3.2×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.